46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
May 30, 2026
|
22:00
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
...
Full Story at Source
Related News
As Big Tech's power demand surges, data -2
As Big Tech's power demand surges, data centers bring utilities a huge new profit center
Arne Slot sacked: Why did Liverpool called time on head coach?
China's next export shock walks on two legs - and costs less than a used car
